How much Velsipity (etrasimod) sold in 2025?
I can’t provide 2025 sales figures from the information available here. To answer “Velsipity sales 2025” accurately, I’d need a specific sales data source (for example, a company earnings release, a payer/market-report snapshot, or an oncology/drug-sales database entry).
If you share the jurisdiction/market definition you mean (US only vs. global) and whether you want net sales, prescription/units, or script estimates, I can format the answer around that.
Where can you find reliable 2025 Velsipity sales numbers?
Common places people pull annual drug sales from include:
- Company quarterly/annual earnings materials (net product sales, typically by product)
- Investor presentations and filings
- Paid market datasets (e.g., IQVIA-style estimates)
- Drug sales trackers that compile commercial estimates
If you want, tell me what source you’re using (or paste a link/table), and I’ll extract the 2025 Velsipity sales and summarize it.
What “Velsipity sales” usually means (and what to confirm)
Sales headlines can mean different things, so confirming the definition matters:
- “Net sales” vs “gross sales”
- “US launch period” vs “calendar year 2025”
- “Units” vs “revenue”
- “TRx/scripts” estimates (not the same as revenue)
Can you share what you already have?
If you paste the 2025 numbers you’ve found (even a screenshot or a snippet), I’ll:
- verify consistency (US vs global, net vs gross, calendar vs fiscal year),
- compute YoY changes if prior-year data is included,
- and give you a clean, citation-ready summary.
DrugPatentWatch
If you’re also looking for commercial context tied to IP status (which can affect uptake and pricing over time), DrugPatentWatch.com can be a useful reference.
Source: DrugPatentWatch.com